Repair of Novaseq6000 next generation sequencing instrument
ID: 75N95025Q00039Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Center for Advancing Translational Sciences (NCATS), is seeking a contractor for the repair of a Novaseq6000 next-generation sequencing instrument. The primary objective of this procurement is to replace the Line Generation Module (LGM), a critical component necessary for the instrument's effective operation in RNA sequencing, which is vital for ongoing stem cell research. The Novaseq6000 plays a significant role in analyzing gene expression profiles, thereby contributing to advancements in diagnostics and therapeutics for various human diseases. Interested contractors should direct their proposals, which must include evidence of technical capability and detailed pricing, to the Contract Specialist, Chandani Hangilipola, at chandani.hangilipola@nih.gov, with a performance period expected to be completed within seven days post-order receipt.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines provisions found in Federal Acquisition Regulation clause 52.204-26, which addresses the use of covered telecommunications equipment or services in federal contracting. It defines critical terms and mandates that Offerors review the System for Award Management (SAM) for any entities excluded from federal awards based on these criteria. The document requires Offerors to represent whether they provide such equipment or services in their offerings to the government, based on a reasonable inquiry. Additionally, it asks for the Offeror to affirm whether they utilize any systems that incorporate this type of equipment or services. This provision is crucial in ensuring that federal contracts do not involve potentially harmful telecommunications products, aligning with national security measures and regulatory compliance in the procurement process. The completion of this representation is certified by an authorized individual from the organization involved. Overall, this provision emphasizes the government's commitment to maintaining security standards in telecommunications through its contracting processes.
    The document is an addendum to FAR 52.212-4 concerning contract terms for commercial products and services, outlining the order of precedence for resolving inconsistencies within a contract. It defines "Commercial supplier agreements" and specifies that terms offered to the public by vendors must be adjusted when the U.S. Government is involved. Key points include the binding nature of agreements, the supremacy of federal law over state laws, and the issuance of unilateral revisions of non-material agreement terms. The document asserts that any automatic renewals require explicit government consent and addresses indemnification rights, including that the U.S. Department of Justice must represent the government in indemnity actions. It also stipulates audit procedures, tax handling, non-assignment conditions, and confidentiality protocols. Overall, the addendum emphasizes federal legal compliance and the specific requirements that govern contracts when the U.S. Government is the end user, aiming to protect government interests while engaging with commercial suppliers.
    This document outlines the Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment, mandated for federal contractors in light of the John S. McCain National Defense Authorization Act of 2019. It specifies prohibitions on procuring or extending contracts for covered telecommunications equipment or services deemed critical technology or essential to systems after specified deadlines. Additionally, the provision includes definitions for key terms and outlines mandatory representations from offerors on whether they will provide or use such covered services or equipment. Offerors must declare their compliance status and provide detailed disclosures if they indicate a positive response to the use of covered telecommunications. Required information includes details about the equipment or services, the producing entities, and the intended use. The document further directs offerors to review the System for Award Management (SAM) for entities excluded from federal awards based on these provisions. This representation process serves to ensure that federal contracts do not involve telecommunications services or equipment that may pose national security risks, reflecting a stringent compliance obligation for all parties in the contracting process with the government.
    The National Institute on Drug Abuse (NIDA) is soliciting a non-competitive request for quotations (RFQ) for the repair of a Novaseq6000 next-generation sequencing instrument through procurement procedures under the Federal Acquisition Regulation (FAR). The contract will be awarded to Illumina Inc. for the replacement of a crucial component, the Line Generation Module (LGM), which is essential for the instrument's performance in sequencing applications. The anticipated period of performance is seven days post-order receipt, with mandatory on-site labor and travel expenses included. Proposals will be evaluated based on technical capability, price, and past performance, following FAR 13.106-2. Contractors must submit evidence of their technical capability and include detailed pricing information, including labor categories and costs. All submissions must adhere to specified deadlines and be directed to the Contract Specialist. This solicitation underscores NCATS’ ongoing research in stem cell translation and the critical role of the Novaseq6000 in advancing therapeutic diagnostics and methodologies.
    The document outlines the necessary contract terms and conditions required for federal acquisitions of commercial products and services, specifically addressing compliance with various Federal Acquisition Regulation (FAR) clauses. These clauses, indicated by the Contracting Officer, include a range of legal and ethical requirements such as restrictions on subcontractor sales, contractor business ethics, whistleblower protections, and labor standards. The document emphasizes the obligation for contractors to adhere to stipulations related to small businesses, equal opportunity, and environmental provisions. Additionally, several clauses specifically address prohibitions on contracting with certain foreign entities and require transparency in subcontracting opportunities. The document serves as a comprehensive guide to ensure that contractors comply with federal laws and executive orders applicable to their contracts, ultimately fostering fair practices and accountability within government contracting. This summary encapsulates crucial contracting requirements relevant to new federal grant proposals and RFPs, ensuring consistency with applicable laws and regulations.
    The document outlines the invoice and payment provisions for contractors engaged with the federal government, particularly under NIH guidelines. It emphasizes the necessity for proper invoice submission, detailing required elements such as vendor information, unique identifiers like the UEI, and descriptions of goods or services. A proper invoice must comply with FAR regulations to avoid delays in payment, which is due either 30 days after receipt or upon governmental acceptance of services. Additionally, it specifies that interest penalties will apply if invoices are not paid on time, provided they meet set criteria. There are also provisions for accelerated payments to small business subcontractors to facilitate their financial stability. Furthermore, it mandates that payment requests be submitted electronically via the Department of Treasury’s Invoice Processing Platform (IPP), with exceptions only if authorized by the Contracting Officer. This document serves to streamline the payment process, ensuring compliance with federal standards and expediting transactions in government contracts, thereby enhancing transparency and efficiency in federal procurement processes.
    This document outlines the invoice and payment provisions applicable to contractors of the National Institutes of Health (NIH). It establishes the requirements for submitting proper invoices and includes specific details such as vendor information, invoice format, unique identifiers, and due dates for payments based on the Prompt Payment Act. Contractors must ensure their invoices meet all specified criteria to avoid delays in processing. The transition to the Department of Treasury's Invoice Processing Platform (IPP) is also discussed, providing guidelines on electronic submission via email. Additionally, the document emphasizes the accelerated payment obligations to small business subcontractors and mandates electronic submission of payment requests unless alternative procedures are authorized. Clear formatting instructions for the email subject line during submission are provided to facilitate proper invoice processing. Overall, this document plays a vital role in ensuring efficient financial transactions between contractors and the NIH while adhering to federal requirements and policies.
    The National Center for Advancing Translational Sciences (NCATS) is seeking to repair a Novaseq6000 next-generation sequencing instrument vital for their stem cell research. This request is prompted by the discovery that a critical component, the Line Generation Module (LGM), requires replacement following a preventative maintenance assessment. The repair is essential for accurate data output used in RNA sequencing to analyze gene expression in human cells. The expected period for completion of this project is within 7 days following the procurement of services. The contractor is responsible for providing all necessary resources, including installation of the new part, on-site labor for a minimum of two hours, and covering travel expenses related to the service. The document details the project's aim to ensure the continuity of ongoing research and the significance of the Novaseq6000 in processing RNA sequencing data, highlighting its role in advancing healthcare diagnostics and therapeutics.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    J--NextSeq2000 Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Child Health and Development (NICHD), intends to award a non-competitive contract to Illumina, Inc. for a maintenance agreement on the NextSeq2000 sequencing system. This agreement is crucial for ensuring the optimal performance of the sequencer, which is utilized for genetic analyses related to mental health conditions, particularly alcohol use disorder. The maintenance contract will cover preventative maintenance, emergency repairs, and necessary updates from December 24, 2024, to December 23, 2025, with Illumina being the sole provider capable of servicing this specialized equipment. Interested parties may submit their qualifications by November 25, 2024, and for further inquiries, they can contact Jacob M. Balenson at jacob.balenson@nih.gov or call 301-827-8302.
    NextSeq 1000 Instrument Maintenance and Repair Support Services
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified contractors to provide maintenance and repair support services for two Illumina NextSeq 1000 instruments. The procurement includes a firm-fixed-price contract with a base period of one year, from November 21, 2024, to November 20, 2025, and three additional option years, covering comprehensive services such as parts, labor, remote technical support, and annual preventative maintenance. These instruments are crucial for public health research and outbreak surveillance, ensuring their reliable operation is vital. Interested contractors must submit their quotations to Kristen Tucker at xvc1@cdc.gov by 3:00 PM EST on November 18, 2024, and must be registered in the System for Award Management to be eligible for consideration.
    Preventive Service Maintenance - NovaSeq 6000 Silver Support Plan
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole source contract for preventive service maintenance of the NovaSeq 6000 sequencing instrument, specifically the Silver Support Plan from Illumina, Inc. This contract, valued at $141,313.00, is crucial for maintaining the high-throughput sequencing capabilities of the Department of Defense's Biological Defense Research Directorate, as Illumina is the original equipment manufacturer and the only provider of authorized service technicians for this specialized equipment. The NMRC has conducted market research confirming the absence of alternative service providers and will ensure fair pricing through a comprehensive analysis prior to the award. Interested parties can reach out to primary contact Shamai M. Carter at shamai.m.carter.civ@health.mil or by phone at 301-319-7182 for further information.
    Preventive Maintenance and Repair Services for a PacBio Sequel II next generation sequencer
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified contractors to provide preventive maintenance and repair services for a PacBio Sequel II next-generation sequencer at the National Center for Toxicological Research (NCTR) in Jefferson, Arkansas. The procurement includes two base years of service with three optional years for extension, requiring one scheduled on-site maintenance visit annually, unlimited corrective maintenance within three days, and ongoing technical support, all using OEM-certified parts. This contract is crucial for ensuring the operational integrity of essential laboratory equipment, with a firm fixed price structure and compliance with federal procurement standards. Interested vendors should contact Warren Dutter at warren.dutter@fda.hhs.gov or call 870-543-7577 for further details regarding the solicitation numbered 75F40125Q124999.
    Sequencing Kits and Accessories for Oxford Nanopore Sequencing Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources to provide sequencing kits and accessories for Oxford Nanopore Sequencing Systems as part of a Sources Sought notice. The primary objective of this procurement is to supply the Center for Alzheimer’s Disease and Related Dementias with essential reagents for neurodegenerative disease research, particularly for long read sequencing aimed at identifying causative genes for conditions like Parkinson’s disease. This initiative is aligned with the Global Parkinson’s Genetics Program (GP2), which aims to genotype over 150,000 volunteers globally to enhance understanding of genetic risk factors. Interested companies must submit their capability statements by November 27, 2024, to Eric McKay at eric.mckay@nih.gov, with the anticipated delivery dates for the supplies spanning from September 30, 2025, to September 30, 2027.
    Service/Maintenance Agreement for the Agilent instrumentation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a service and maintenance agreement for Agilent instrumentation utilized at the National Center for Advancing Translational Sciences (NCATS). This procurement aims to ensure the operational integrity and performance of Agilent Liquid Chromatography/Mass Spectrometry (LCMS) systems, which are critical for various research applications, including high-throughput mass spectrometry analysis. The contract, valued at an estimated amount not exceeding $7.5 million, is intended to be awarded on a sole-source basis to Agilent Technologies Inc., as they are the only authorized provider capable of maintaining these systems without voiding existing warranties. Interested parties must submit their capabilities and proposals by November 22, 2024, to Patricia da Silva at patricia.dasilva@nih.gov.
    SERVICE CONTRACT FOR FACSYMPHONY S6 CELL SORTER AND (5) VARIOUS LASERS
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIAID, is seeking quotations for a service contract for a FACSymphony S6 Cell Sorter and five various lasers, essential for maintaining optimal operational conditions for critical research equipment. The procurement aims to establish a one-year service agreement that includes full coverage for OEM replacement parts, labor, and travel, along with preventive maintenance inspections and remote technical support to ensure minimal downtime for the Vaccine Research Center's ongoing projects. This service is vital for the continuous operation of the equipment used in AIDS vaccine development, underscoring its importance to the NIH's research efforts. Interested vendors must submit their quotations by the specified deadline, ensuring they are registered in the System for Award Management (SAM) and can meet all outlined requirements, with contact inquiries directed to Rubyanne Matthews at rubyanne.matthews@nih.gov or Jesse Weidow at jesse.weidow@nih.gov.
    SERVICE AGREEMENT FOR A FACSYMPHONY S6 SORTER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking a qualified contractor to provide a service agreement for a FACSymphony S6 sorter and associated lasers, essential for maintaining optimal operation of flow cytometry equipment used in critical research. The contract includes provisions for preventive maintenance inspections, unlimited service visits, and priority onsite scheduling to minimize downtime, ensuring that the equipment remains functional for ongoing research into immune responses in HIV- and SIV-infected samples. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 25, 2024, with the contract period set from February 1, 2025, to January 31, 2026. For further inquiries, vendors can contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Transcriptomics Sequencing and analysis in Liver Spheroids
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Center for Advancing Translational Sciences (NCATS), is seeking a contractor to provide transcriptomics sequencing and analysis in liver spheroids to evaluate the hepatotoxicity of antisense oligonucleotides (ASOs). The primary objective of this contract is to develop a predictive model for assessing the safety and acute toxicity of ASO therapies, particularly for rare diseases, by utilizing 3D liver microtissue platforms to replace traditional animal studies. This initiative is crucial for enhancing the safety profiles of potential ASO therapies intended for clinical use, addressing significant public health concerns. Interested parties can contact Chandani Hangilipola at chandani.hangilipola@nih.gov or call 13014807089 for further details, with the project expected to commence on October 20, 2024, and conclude by December 20, 2024.
    Annual Renewal of Gold GeoMx Sys Contract for GeoMx DSP Analysis Instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the annual renewal of a maintenance contract for the Gold GeoMx DSP Analysis Instrument, crucial for ongoing research at the National Institute of Allergy and Infectious Diseases (NIAID). The procurement aims to ensure the optimal functioning of this essential equipment through a service agreement that includes one annual maintenance visit, unlimited emergency visits, and priority technical support, with a strict requirement for a 72-hour response time for repairs. This initiative underscores the government's commitment to maintaining critical research capabilities, as the equipment is vital for NIAID investigators' work. Interested vendors must submit their quotations by November 21, 2024, and can direct inquiries to Dana Monroe at dana.monroe@nih.gov or by phone at 406-375-9814.